Clinical Therapeutics
Volume 34, Issue 1 , Pages 1-13, January 2012

Fidaxomicin: The Newest Addition to the Armamentarium Against Clostridium difficile Infections

  • Jason W. Lancaster, PharmD, BCPS

      Affiliations

    • Corresponding Author InformationAddress correspondence to: Jason W. Lancaster, PharmD, BCPS, Department of Pharmacy Practice, School of Pharmacy, Bouvé College of Health Sciences, Northeastern University, 360 Huntington Avenue, 206 Mugar Life Sciences Building, Boston, MA, 02115
    • ,
  • S. James Matthews, RPh, PharmD

Department of Pharmacy Practice, School of Pharmacy, Bouvé College of Health Sciences, Northeastern University, Boston, Massachusetts

Accepted 9 December 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0149-2918(11)00838-1

doi:10.1016/j.clinthera.2011.12.003

Clinical Therapeutics
Volume 34, Issue 1 , Pages 1-13, January 2012

Article Tools

* Image Usage & Resolution